All News

Robert B Chao, MD Tweet
doctorRBC
Healthy behaviors (moderate EtOH, healthy body weight, no smoking, healthy diet, physical activity) associated with lower RA risk "Chronic systemic inflammation fans the flames of brewing RA" @RheumNow #RNL2022 https://t.co/gAerZaAcso
Robert B Chao, MD Tweet
doctorRBC
Completed Early RA prevention trials using agents like steroids, RTX, atorvastatin, abatacept No sig difference in steroids, atorvastatin RTX delayed onset but no overall diff Abatacept decreased RA progression at 1.5 years @RheumNow #RNL2022 https://t.co/v7WxI2P7r5
Elena MyasoedovaMD Tweet
MyasoedovaElena
@Janetbirdope on drug cycling in #RA. What’s beyond TNFi failure? No golden rule, but: 👉🏻 switching to non-TNF can be superior than staying with the TNFi class 👉🏻 response to other bDMARs maybe blunted in non-TNFi naive 👉🏻 JAKi can be a good choice for some @RheumNow #RNL2022 https://t.co/25MiiFh2CK
TheDaoIndex Tweet
KDAO2011
Patients often ask me what they can do on their part to help their disease... this is it! @karen_kc123 reviews the modifable risks in RA. @rheumnow #RNL2022 @CreakyJoints https://t.co/FM0BtNX6eb
Janet Pope Tweet
Janetbirdope
#Rheumatoid arthritis- is it all or partially in your genes 🧬? Many genes are not sufficient or necessary to produce #RA. Genes were used in a study to predict development of RA better than clinical parameters. But not ready for prime time YET #RNL2022 @RheumNow @karen_kc123 https://t.co/J5aBs4iLbR
Robert B Chao, MD Tweet
doctorRBC
Dr. Elena Myasoedova on Multimorbidities and RA Important to recognize multimorbities are 2-3x higher in RA and how it impacts our RA pts @RheumNow #RNL2022 https://t.co/N6VPdU6wzV
Robert B Chao, MD Tweet
doctorRBC
@Janetbirdope on drug cycling vs. switching in RA Interesting data showing switching to non-TNFi superior to cycling in TNFi-incomplete responders Most bDMARDs and JAKi have blunted response post-TNFi @RheumNow #RNL2022 https://t.co/Lb3wvHZdzN
Robert B Chao, MD Tweet
doctorRBC
Retention of JAKinibs longer than bDAMRDs in RA Interesting but wonder how this will be affected given new FDA warnings. @RheumNow #RNL2022 https://t.co/Gj2wBFbaAj
Janet Pope Tweet
Janetbirdope
#ClinicalPearl #multimorbidity worsens outcomes in #rheumatoid arthritis. 50% of #RA pts has this and 2x > than age sex matched pop’n. Worse as interplay of diseases, drug disposition, med adherence, drug interactions, etc #RNL2022 ⁦@RheumNow⁩ Elena Myasoedova https://t.co/aTF0O8o0tg
TheDaoIndex Tweet
KDAO2011
Dr. Elena Myasoedova defines multimorbidity and its difference for comorbidities. Multimorbidity (MM) focuses on the patient, comorbidities focuses on the disease. RA pts have 2.3 X higher MM and can precede RA. #RNL2022 @rheumnow https://t.co/FE489rJnnP
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×